Clinical credibility Speechagain is a cloud-based, AI-driven stuttering therapy with a long-standing scientific foundation from the Kassel Stuttering Institute and a track record of treating over 3,000 people with a long-term success rate above 75%, which can be leveraged to target healthcare providers and clinics seeking proven, scalable therapy solutions.

Digital therapy The platform combines cloud delivery, AI and speech recognition to offer online therapy, suggesting opportunities to partner with hospitals, telehealth services, and academic medical centers looking to expand remote speech therapy offerings.

Recognition & awards Award recognition such as the Eugen Münch award for innovative healthcare enhances credibility when approaching ascendant healthcare networks and grant-funded programs that value innovative, outcome-driven digital therapies.

Growth channels Historical launches include college ambassador programs and a patented online training program, indicating potential to collaborate with universities, student health services, and early adopter clinics to drive adoption and brand awareness.

Market positioning With a small team and revenue in the lower end of the spectrum, there is an opportunity to position Speechagain as a scalable, cost-effective digital therapy within hospital systems, speech-language pathology groups, and independent clinics seeking high ROI digital tools.